Antitumor effect of invasive Lactobacillus plantarum delivering associated antigen gene sHSP between Trichinella spiralis and Lewis lung cancer cells

Int Immunopharmacol. 2023 Feb:115:109708. doi: 10.1016/j.intimp.2023.109708. Epub 2023 Jan 11.

Abstract

Cancer is a frequent disease that seriously harms human health, but there are no ideal therapies for it. Currently, some food-grade microorganisms such as Lactobacillus plantarum have shown better anti-tumor effects. Here, recombinant Lactobacillus plantarum lives vector vaccine NC8-sHSP was generated by using the invasive Lactobacillus plantarum NC8 expressing FnBPA to deliver the associated antigen gene sHSP between trichinella spiralis and Lewis lung cancer cells (LLC) to host cells. NC8-sHSP colonized the mouse intestine to deliver plasmids to intestinal epithelial cells and controlled the growth of LLC by inducing humoral, cellular, and mucosal immunity. The tumor inhibition rates were 62.36% and 68.37% in the prophylactic assay and 40.76% and 44.22% in the treatment assay, respectively. Recombination of Lactobacillus plantarum did not cause significant damage. In conclusion, the recombinant invasive Lactobacillus plantarum constructed in this study has better anti-Lewis lung cancer effects in mice, which will provide new ideas for the application of food-grade microorganisms in anti-tumor and the development of oral tumor vaccines.

Keywords: Lactobacillus plantarum; Lewis lung cancer; Trichinella spiralis; Tumor vaccines; sHSP.

MeSH terms

  • Animals
  • Humans
  • Lactobacillus plantarum* / genetics
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / therapy
  • Mice
  • Plasmids
  • Trichinella spiralis* / genetics